Michael Haude

Michael Haude publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael Haude sits on this spectrum.

Michael Haude D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Haude sits on this spectrum.

Overview

Best Publications

• Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention : A Consensus Document From the Academic Research Consortium for High Bleeding Risk

  Philip Urban;Roxana Mehran;Roisin Colleran;Dominick J. Angiolillo

  1329
  Citations

• Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial

  Raimund Erbel;Carlo Di Mario;Jozef Bartunek;Johann Bonnier

  1065
  Citations

• Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

  Patrick W. Serruys;Ben Van Hout;Hans Bonnier;Victor Legrand

  894
  Citations

• Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

  Pascal Vranckx;Marco Valgimigli;Peter Jüni;Christian Hamm

  761
  Citations

• A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

  Patrick W Serruys;Bernard Chevalier;Dariusz Dudek;Angel Cequier

  706
  Citations

• Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

  Patrick W Serruys;Bernard Chevalier;Yohei Sotomi;Angel Cequier

  591
  Citations

• Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

  Davide Capodanno;Anna S. Petronio;Bernard D. Prendergast;Helene Eltchaninoff

  524
  Citations

• Coronary microembolization: from bedside to bench and back to bedside.

  Gerd Heusch;Petra Kleinbongard;Dirk Böse;Bodo Levkau

  500
  Citations

• Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

  Michael Haude;Raimund Erbel;Paul Erne;Stefan Verheye

  495
  Citations

• Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European Association of Percutaneous Cardiovascular Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the European Society of Cardiology.

  Martial Hamon;Christian Pristipino;Carlo Di Mario;James Nolan

  477
  Citations

• Prognostic Value of Intracoronary Flow Velocity and Diameter Stenosis in Assessing the Short- and Long-term Outcomes of Coronary Balloon Angioplasty: The DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe)

  P.W. Serruys;C. di Mario;J.J. Piek;E. Schroeder

  427
  Citations

• Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group.

  R Erbel;M Haude;H W Höpp;D Franzen

  400
  Citations

• Percutaneous Mitral Annuloplasty for Functional Mitral Regurgitation Results of the CARILLON Mitral Annuloplasty Device European Union Study

  Joachim Schofer;Tomasz Siminiak;Michael Haude;Jean P. Herrman

  400
  Citations

• Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial

  Michael Haude;Hüseyin Ince;Alexandre Abizaid;Ralph Toelg

  400
  Citations

• Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.

  Bernard Iung;Victoria Delgado;Raphael Rosenhek;Susanna Price

  393
  Citations

• Percutaneous Left Ventricular Support With the Impella 2.5 Assist Device in Acute Cardiogenic Shock - Results of the Impella EUROSHOCK-Registry

  Alexander Lauten;Annemarie E. Engström;Christian Jung;Klaus Empen

  391
  Citations

• Comparison of intravascular ultrasound and angiography in the assessment of myocardial bridging.

  J Ge;R Erbel;H J Rupprecht;L Koch

  371
  Citations

• Comparison of Electron Beam Computed Tomography With Intracoronary Ultrasound and Coronary Angiography for Detection of Coronary Atherosclerosis

  Dietrich Baumgart;Axel Schmermund;Guenter Goerge;Michael Haude

  365
  Citations

• Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo

  Clemens von Birgelen;Wolfgang Klinkhart;Gary S Mintz;Alexandra Papatheodorou

  328
  Citations

• Letter by Xia regarding article, "High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor".

  Gregor Theilmeier;Christoph Schmidt;Jörg Herrmann;Petra Keul

  4
  Citations